|
|
|
1. Markovic O, Markovic N, and BioSciCon Cervical Cancer
Study Group. Cervical acid phosphatase: A biomarker of cervical dysplasia
and potential surrogate endpoint for colposcopy. Disease Markers
2003/2004;19(6): 279-286. 2. Markovic O. Markovic N. MarkPap® Research Kit 3. Markovic N, Markovic O. Enhancing Pap test with a new biological
marker of cervical dysplasia International Symposium on Predictive
Oncology & Intervention Strategies, Nice, France, 2004. Cancer Detect
Prevention 2004 Symposium Volume, S-53(21). 4. Markovic O, Markovic N, and BioSciCon Cervical Cancer Study Group.
MarkPap™ Kit. Cancer Detect Prevention, 2004 Symposium
Volume, S-149(318). 5. Markovic O, Markovic N, et al. Cervical acid phosphatase: A new biomarker of cervical dysplasia. Arch Oncol 2003;11:243-247. 6. Markovic O, Markovic N, Sundeen J, Smith W. Jr. A cytoplasmic biomarker for liquid-based Pap. The FACEB J. Experimental Biology 2004, Abstracts Part 1, A200 (151.12). 7. Smith W Jr, Markovic N, Markovic O, Kumar A, Bermeyo S, Mollish P, late Morris M. MarkPap™ System for cervical cancer screening. Power Point presentation at the 2004 Biennial Meeting of the American Society for Colposcopy and Cervical Pathology. Disney's Contemporary Resort, FL. 2004 ASCCP Book of Abstracts, p.340. 8. Townsend L, Markovic O, Markovic N, BioSciCon Cervical Cancer Study Group. MarkPap™test reduces false-negative rates of cervical cancer screening Obst Gynec 2004 Suppl; 103(4):81S. 9. Markovic NS, Markovic O, Sundeen J, Smith W, Jr., Markovic SN, BioSciCon
Cervical Cancer Study Group. Pap test and new biomarker-based technology
for enhancing visibility of abnormal cells. ASCO 2004, New Orleans,
Louisiana. J Clin Oncol 2004; 22:9561. 10. Markovic N, Markovic O, Sundeen J, Smith W. Jr. Cervical Acid Phosphatase and PreservCyt®. Inv Medicine 2004; 52 Suppl 2: 80. 11. Markovic N, Markovic O. MarkPap® technology. From idea to commercial products. A biomarker based, in vitro diagnostic device with potentials for cervical cancer screening. 2004, 3rd Annual Early Detection Research Network Meeting, EDRN NIH, Bethesda, MD. 12. Markovic O, Markovic N, BioSciCon Cervical Cancer Study Group. MarkPap® Technology for cervical cancer screening. 2004, 6th Annual SBIR/STTR Conference, NIH, Bethesda, MD. 13. Markovic O, Markovic N, Kemp C. Could the enzyme-enhanced Pap test be automated? The FACEB J, Experimental Biology 2004, Abstracts Part 1, A200 (151.10). 14. BioSciCon Business Presentation, 2003 15. Markovic O, Markovic N, Cervical Cancer Study Group. MarkPap® System for cervical cancer screening and for molecule-targeting cancer therapy. EB 2005, FASEB J, 2005, 18. Online Abstract Itinerary 16. Markovic N, Markovic O, Henderson E, BioSciCon Cervical Study Group.
MarkPap® test for cervical cancer screening. 2005 Annual
Meeting of the American Society for Clinical Oncology (ASCO, 2005). 17. BioSciCon Business Presentation, 2006 18. Markovic N, Markovic O, Parr S, Zizic V. MarkPap(r) technology
for cervical cancer control. BIO 2005 Convention. You will find a
link to the abstract on this page: 19. Markovic O, Markovic N. Biomarker improves the accuracy of Papanicolaou-based screening for cervical dysplasia. Abstracts of Papers and Poster Presentations, 2005 Scientific Sessions of the Annual Meeting of the Society for Clinical Pathology (ASCP), Seattle, WA (Abstract # 19). http://www.ajcp.com/Oct05Abstracts.pdf. 20. Markovic N, Markovic O. MarkPap Test and papillomavirus–infected cells. Abstracts of Papers and Poster Presentations, Scientific Sessions of the Annual Meeting of the Society for Clinical Pathology (ASCP), October 2005, Seattle, WA (Abstract # 35). http://www.ajcp.com/Oct05Abstracts.pdf. 21. Markovic O, Markovic N. MarkPap® System. Current status and prospective. 2005 Annual Meeting of the American Society for Cytopathology, San Diego, CA (Abstract # 39). 22. Markovic O, Markovic N, Hankins D, McJonathan S, Hill G. New prospective for MarkPap® technology for cervical cancer control. BIO 2006 Convention, Innovative Corridor, April 2006, Chicago, IL. 23. Markovic N, Markovic O, Henderson E. MarkPap Digital, a new prospective for biomarker-based gynecological cytology. Annual Meeting of the American Association for Cancer Research (AACR), April 2006, Washington, DC. 24. Markovic N, Markovic O. MarkPap® test, a potential method for monitoring the success of HPV vaccination. Clinical Research 2006, Annual Meeting of the American Federation for Clinical Research (AFCR), March 2006, Washington, DC. J Investigative Medicine 54, (2), S381, 2006. 25. Markovic O, Markovic N, Townsend L, Smith W Jr, Hankins D, Cotic M, McJonathan S. Pap test moves into doctor's offices. Clinical Research 2006, Annual Meeting of the American Federation for Clinical Research (AFCR), March 2006, Washington, DC. J Investigative Medicine 54, (2), S381, 2006. 26. Markovic N, Markovic O, BioSciCon Cervical Cancer Study Group: Biomarker-based telecytopathology: A new prospective for global cervical cancer control. 4th Early Detection Research Network, National Cancer Institute, NIH, Philadelphia, March 2006, Philadelphia, PA 2006. Book of Abstracts, 23, 2006. 27. Markovic O., Markovic N. MarkPap technology, new deployment. FASEB Annual Meeting, Experimental Biology 2006, San Francisco, CA : Abstract LB 540. http://www.faseb.org/...eb_late_breaking_volume.pdf 28. Markovic O, Markovic N. MarkPap technology: A prospective for global cervical cancer control. FASEB Annual Meeting, Experimental Biology 2006, San Francisco, CA. 29. Markovic N, Markovic O. MarkPap(r) technology, a new business opportunity for the Mid-Atlantic biotechnology . Mid-Atlantic BIO 2006, Washington DC. To see the abstract of the presentation click here. 30. Markovic N, Markovic O. Cytopathology between art and science. Experimental Biology 2007. The FASEB J 2007: 21 (6), A 772, 714.7 31. Markovic O, Markovic N. Will Home Pap Test be soon available? Experimental Biology 2007. The FASEB J 2007 : 21 (6), A 754, 708.10 32. Markovic N, Markovic O. MarkPap test and HPV vaccination. BIO International Convention, BIO 2007, Innovation Corridor. Boston, MA, 2007. 33. Markovic N. BioSciCon business opportunities. Larta NIH-Commercialization Assistance Program Outcome Workshop, March, Washington, DC 34. Markovic N. BioSciCon presents the MarkPap technology. Larta-CAP Venture Forum 2007, San Francisco, CA, May 2007. 35. BioSciCon Past, Present and Future. Business presentation, 2007. 36. Markovic N, Markovic O. Biomarker Plus. 55th Annual Meeting of the American Society of Cytopathology, Nov 2007, Houston, Texas. Cancer Cytopathology Suppl. 11/5,385,2007 37. Markovic N, Markovic O. Ask for women' s opinion first. Teaching and Computer Session. FASEB Experimental Biology, 2008. Today's Research: Tomorrow's Health. San Diego California, April 5-9, 2008. 38. Deb Prabal, Iyer Wenkateswaran, Bhatla Neerja, Olivera Markovic, Verma Kusum. Cervical acid phosphatase detection: A guide to abnormal cells in cytology smear screening for cervical cancer. Journal of Cytology, 25 (1),1-5, 2008. 39. Markovic N, Markovic O, Panashchenko O, McJonathan S. A tool for integration of cytology, HPV screening and telecytopathology. BIO 2008 International Convention. San Diego, California, June 2008. 40. What Every Women Should Know about Cervical Cancer. Markovic N, Markovic O (eds). Springer, 2008. |
 |
||
|
